M. Sieber

Time-intensified dexamethasone/cisplatin/cytarabine:an effective salvage therapy with low toxicity in patients with relapsed and refractory Hodgkin’s disease

Andreas Josting, Christian Rudolph, Marcel Reiser et al. · Annals of Oncology · 2002 · 222 citations · Full text

Medicine, Oncology, Pharmacology +14

Male gonadal dysfunction in patients with Hodgkin’s disease prior to treatment

U. Rueffer, Kai Breuer, Andreas Josting et al. · Annals of Oncology · 2001 · 203 citations

Medicine, Endocrinology, Reproductive Endocrinology +13

BEACOPP, a new dose-escalated and accelerated regimen, is at least as effective as COPP/ABVD in patients with advanced-stage Hodgkin's lymphoma: interim report from a trial of the German Hodgkin's Lymphoma Study Group.

Volker Diehl, Jeremy Franklin, Dirk Hasenclever et al. · Journal of Clinical Oncology · 1998 · 196 citations

Medicine, Oncology, Pharmacotherapy +15

Cologne high-dose sequential chemotherapy in relapsed and refractory Hodgkin lymphoma: results of a large multicenter study of the German Hodgkin Lymphoma Study Group (GHSG)

Andreas Josting, Christian Rudolph, MY Mapara et al. · Annals of Oncology · 2004 · 159 citations · Full text

Medicine, Oncology, Chemotherapy +14

BEACOPP: An intensified chemotherapy regimen in advanced Hodgkin's disease

Volker Diehl, M. Sieber, U. Rüffer et al. · Annals of Oncology · 1997 · 155 citations

Medicine, Oncology, Pharmacology +9